Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginTimes Interest Earned

Cellectis (CLLS) Invested Capital (2016 - 2025)

Cellectis has reported Invested Capital over the past 12 years, most recently at $190.0 million for Q4 2025.

  • Quarterly results put Invested Capital at $190.0 million for Q4 2025, down 29.49% from a year ago — trailing twelve months through Dec 2025 was $190.0 million (down 29.49% YoY), and the annual figure for FY2025 was $190.0 million, down 29.49%.
  • Invested Capital for Q4 2025 was $190.0 million at Cellectis, down from $269.4 million in the prior quarter.
  • Over the last five years, Invested Capital for CLLS hit a ceiling of $376.2 million in Q4 2021 and a floor of $76.1 million in Q3 2023.
  • Median Invested Capital over the past 5 years was $190.0 million (2025), compared with a mean of $193.5 million.
  • Biggest five-year swings in Invested Capital: tumbled 57.79% in 2023 and later surged 162.25% in 2024.
  • Cellectis' Invested Capital stood at $376.2 million in 2021, then crashed by 35.29% to $243.4 million in 2022, then plummeted by 57.79% to $102.7 million in 2023, then surged by 162.25% to $269.4 million in 2024, then fell by 29.49% to $190.0 million in 2025.
  • The last three reported values for Invested Capital were $190.0 million (Q4 2025), $269.4 million (Q4 2024), and $102.7 million (Q4 2023) per Business Quant data.